Wall Street Analyst Updates: Nvidia, Tesla, and Eli Lilly Among Key Rating Changes
Major financial institutions issued several significant rating updates on Monday. Barclays reiterated an overweight rating for Eli Lilly (LLY) with a raised price target of $1,550, citing growing volume opportunities despite pricing debates. In the technology sector, UBS maintained a buy rating on Nvidia (NVDA) but lowered its price target to $240 ahead of upcoming earnings, forecasting strong revenue growth driven by the Rubin architecture. Automotive and aerospace saw notable activity as JPMorgan reiterated a neutral stance on Tesla (TSLA), noting early validation in its robotaxi and physical AI capabilities. Meanwhile, Citi raised its price target for SpaceX to $280 following successful Starship milestones. Other significant moves included upgrades for Nucor (NUE) by UBS and Viking Holdings (VIK) by Mizuho, as analysts identified potential inflection points and transitory headwinds.

Tickers: $BILL $BTU $CCL $LEU $LLY $NUE $NVDA $RCL $SPXT $TSLA $VIK $YSS
Topics: Earnings Expectations Price Target Changes Stock Analyst Ratings